The recommended maximum daily dose of Zoloft , also known by its generic name Sertraline, is 200mg per day
2023GLP-1 GLP-1 GLP-1LGlucagon-like peptide-1 receptor agonists, GLP-1RAGLP-1-1 2022GLP-1GLP-19%31%1 GLP-1GLP-11849760216GLP-1/GIPGLP/GIP/GCGR Glucose-dependent insulinotropic polypeptide, GIPGLP-1 GLP-120222023 GLP-1 SemaglutideOzempicRybelsusWegvoy 2022110202343GLP-1GLP-1Liraglutide202216 TirzepatideGLP-1/GIP20225FDANature Medicine 94.835.68202330GLP-1SVB Securities2030264 4300GLP-1 LY3437943RetatrutideGLP-1R/GIPR/GCGR5623 Insight 112 GLP-116202217GLP-1Mazdutide GLP-1GLP-120%44%700 GLP-164.4%GLP-1 GLP-16272023 ADAGIPR/GLP-1R/GCGRRetatrutide 83%Retatrutide12 mg2415%4824.2% GLP-1 GLP-1 Retatrutide(NASH)Retatrutide8mg12mg80%70%80%4885% NASHEvaluate Pharm20253501500-30005000 RetatrutideNASHMadrigalVikingTernsA62818.21% GLP-1NASHGLP-1GLP-1NASH 202050%GLP-1Retatrutide GLP-1 EMAGLP-1GLP-1LotiglipronGLP-1R/GCGRGLP-1RAZD0186 2III5GLP-1GLP-1 GLP-1 |ID:songguocaijing1
In one study, people lost an average of 4% of their weight in 16 weeks
Additionally, during the 68-week treatment period, although weight loss slowed, it did not plateau, suggesting that a longer treatment period may be necessary to achieve the maximum benefits of semaglutide 2.4 mg in this patient population, which this trial did not capture
In addition, Semaglutide is licensed to treat type 2 diabetes, and Retatrutide has not been approved yet for any medicinal use
Although the risk appears to be extremely low, it serves as a reminder that all medications carry both benefits and risks